Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Alimta and Gemcitabine in Non-Small Cell Lung Cancer (ANGEL)

This study has been completed.
Sponsor:
Information provided by:
Southern Italy Cooperative Oncology Group
ClinicalTrials.gov Identifier:
NCT00434135
First received: February 9, 2007
Last updated: February 4, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)